Insider Trading History of Shukla Sath

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Shukla Sath since 2023. This trader's CIK number is 1782817. At the time of last reporting, Shukla Sath was the CEO & President of Spero Therapeutics, Inc.. (stock ticker symbol SPRO). Also see all insider trading activities at Spero Therapeutics, Inc..


Yearly summary of insider trading at Spero Therapeutics, Inc. (SPRO) by Shukla Sath

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 SPRO 0 $0 155,333 $121,159 0 $0
2024 SPRO 0 $0 111,192 $154,084 0 $0
2023 SPRO 0 $0 15,521 $25,120 0 $0


Insider trading of Spero Therapeutics, Inc. (SPRO) by Shukla Sath

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-02-05 SPRO Sale 155,333 .78 121,159
2024-08-27 SPRO Sale 2,757 1.35 3,721
2024-08-02 SPRO Sale 14,800 1.32 19,536
2024-08-05 SPRO Sale 17,641 1.31 23,109
2024-02-05 SPRO Sale 45,093 1.45 65,384
2024-02-02 SPRO Sale 30,901 1.37 42,334
2023-08-29 SPRO Sale 4,163 1.30 5,411
2023-08-28 SPRO Sale 1,854 1.26 2,336
2023-02-02 SPRO Sale 9,504 1.83 17,373

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shukla Sath (CEO & President of Spero Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.